What is the most effective treatment for extensive actinic keratoses in an 89-year-old male with hypertension?

Treatment Recommendation for Extensive Actinic Keratoses

For this 89-year-old patient with extensive actinic keratoses involving multiple anatomic sites (scalp, face, arms), field-directed treatment with 5-fluorouracil 5% cream is the most effective therapy, with the strongest evidence for sustained lesion clearance at 12 months. 1

Rationale for Field-Directed Treatment

This patient has clear field cancerization—the "sandpaper texture" on dorsal forearms and multiple rough, scaly patches across sun-exposed areas indicate both clinical and subclinical lesions requiring field treatment rather than lesion-directed approaches. 1

Field-directed therapies address:

• Multiple visible lesions simultaneously
• Subclinical dysplastic changes in surrounding skin
• Prevention of new lesion development
• Reduction in recurrence rates

Evidence-Based Treatment Hierarchy

First-Line: 5-Fluorouracil 5% Cream

This receives a STRONG recommendation with MODERATE quality evidence 1

• Superior long-term efficacy: At 12 months post-treatment, 5-FU demonstrated 74.7% cumulative probability of remaining treatment-failure-free, significantly outperforming all other field therapies 2
• Hazard ratios for treatment failure compared to 5-FU: imiquimod (HR 2.03), PDT (HR 2.73), ingenol mebutate (HR 3.33) 2
• Application: Typically applied once or twice daily for 2-4 weeks depending on anatomic site and formulation 1

Second-Line: Imiquimod 5% Cream

STRONG recommendation with MODERATE quality evidence 1

• Effective but inferior to 5-FU at 12-month follow-up (53.9% vs 74.7% treatment success) 2
• May be preferred if patient cannot tolerate 5-FU inflammatory response
• Application: 2-3 times weekly for 4-16 weeks depending on protocol 1

Third-Line Options

Photodynamic Therapy (PDT): CONDITIONAL recommendation with LOW to MODERATE evidence 1

• ALA-red light or MAL-red light PDT effective for individual lesions
• Better cosmetic outcomes than cryotherapy 3
• Daylight PDT is less painful than conventional PDT with equivalent efficacy 4
• However, 37.7% treatment success at 12 months—substantially lower than 5-FU 2

Cryotherapy with Liquid Nitrogen: STRONG recommendation as Good Practice Statement 1

• Appropriate for limited number of lesions, not extensive disease
• This patient's widespread involvement makes cryotherapy impractical as monotherapy
• Can be combined with field therapy for particularly thick lesions

Diclofenac 3% Gel: CONDITIONAL recommendation with LOW quality evidence 1

• Least effective option among field therapies
• Carries NSAID black box warning for cardiovascular and gastrointestinal effects—particularly relevant in an 89-year-old with hypertension 1
• Should be avoided in this patient given age, comorbidity, and superior alternatives

Critical Considerations for This Patient

Age and Comorbidity Factors

At 89 years old with hypertension, treatment selection must balance:

• Efficacy (preventing progression to squamous cell carcinoma)
• Tolerability (local inflammatory reactions)
• Safety (systemic absorption concerns)
• Compliance (ability to apply treatments correctly)

The guideline explicitly states that for patients with limited life expectancy, observation may be considered if treatment morbidity outweighs benefits 1. However, given this patient's well-controlled hypertension and routine follow-up attendance, treatment is appropriate.

Treatment Algorithm for This Patient

1. Initiate 5-FU 5% cream to face and scalp (highest risk areas for progression)

   • Treat one anatomic region at a time to manage inflammatory response
   • Expected course: 2-4 weeks per region

2. Sequential treatment of arms after facial/scalp healing

   • Allows monitoring of tolerance and adverse effects
   • Prevents overwhelming inflammatory burden

3. Consider combination approach for hyperkeratotic lesions

   • Pre-treat thick lesions with cryotherapy, then apply field therapy 1
   • Evidence supports 5-FU plus cryotherapy over cryotherapy alone (CONDITIONAL recommendation, MODERATE evidence) 1

4. Maintenance strategy after initial clearance

   • Repeat field treatment of previously affected areas
   • High recurrence rates (up to 50% within first year) necessitate ongoing surveillance 1

Common Pitfalls to Avoid

• Do not use diclofenac in this elderly patient with hypertension—cardiovascular risks outweigh modest benefits 1
• Do not attempt cryotherapy alone for extensive disease—impractical and inferior outcomes for field cancerization
• Do not undertreated due to age—untreated AKs carry progression risk to invasive SCC
• Warn patient about expected inflammatory response with 5-FU (erythema, crusting, erosion)—this indicates treatment efficacy, not treatment failure
• Do not treat all anatomic sites simultaneously—staged approach improves tolerability

Monitoring and Prevention

• UV protection receives STRONG recommendation 1
• Regular dermatologic surveillance for new lesions and potential SCC development
• Self-examination education for changing lesions requiring biopsy

The evidence unequivocally supports 5-fluorouracil 5% cream as first-line field therapy for this patient's extensive actinic keratoses, with the 2019 randomized trial demonstrating clear superiority over all alternatives at clinically meaningful 12-month follow-up. 2